Pharmacogenomics information for registered medicines in Zimbabwe: Systematic review of approved Summary of Product Characteristics

Analytical review of the Summary of Product Characteristics for drug with a Dutch Pharmacogeenetics Working Group (DPWG) Testing recommendation registered in Zimbabwe as of 1 February 2026. The SmPCs were systematically reviewed for pharmacogenomic information content and scored according to DPWG criteria fpr SmPC PGx information for clinical implication scoring. This is a pilot project of the Consortium for Genomics and Therapeutics in Africa (CGTA) to assess regulatory approved drug information.